SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000902664-23-001328
Filing Date
2023-02-09
Accepted
2023-02-09 10:54:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMBRX BIOPHARMA INC. p23-0670sc13ga.htm SC 13G/A 101505
  Complete submission text file 0000902664-23-001328.txt   103121
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 (617) 867-2800
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) CIK: 0001165408 (see all company filings)

IRS No.: 043574590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 729-3339
Ambrx Biopharma Inc. (Subject) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92634 | Film No.: 23602005
SIC: 2836 Biological Products, (No Diagnostic Substances)